404 related articles for article (PubMed ID: 19565488)
21. Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.
Yoshimoto K; Takahashi Y; Ogasawara M; Setoyama Y; Suzuki K; Tsuzaka K; Abe T; Takeuchi T
Int Immunol; 2006 Jul; 18(7):1189-96. PubMed ID: 16740602
[TBL] [Abstract][Full Text] [Related]
22. APRIL levels strongly correlate with IL-17 in systemic lupus erythematosus.
Eilertsen GØ; Nossent JC
Lupus; 2014 Nov; 23(13):1383-91. PubMed ID: 25057039
[TBL] [Abstract][Full Text] [Related]
23. Intravenous immunoglobulin and cytokines: focus on tumor necrosis factor family members BAFF and APRIL.
Le Pottier L; Sapir T; Bendaoud B; Youinou P; Shoenfeld Y; Pers JO
Ann N Y Acad Sci; 2007 Sep; 1110():426-32. PubMed ID: 17911457
[TBL] [Abstract][Full Text] [Related]
24. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus.
Jacobi AM; Odendahl M; Reiter K; Bruns A; Burmester GR; Radbruch A; Valet G; Lipsky PE; Dörner T
Arthritis Rheum; 2003 May; 48(5):1332-42. PubMed ID: 12746906
[TBL] [Abstract][Full Text] [Related]
25. TACI, an enigmatic BAFF/APRIL receptor, with new unappreciated biochemical and biological properties.
Mackay F; Schneider P
Cytokine Growth Factor Rev; 2008; 19(3-4):263-76. PubMed ID: 18514565
[TBL] [Abstract][Full Text] [Related]
26. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
27. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.
Mackay F; Tangye SG
Curr Opin Pharmacol; 2004 Aug; 4(4):347-54. PubMed ID: 15251127
[TBL] [Abstract][Full Text] [Related]
28. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
[TBL] [Abstract][Full Text] [Related]
29. BAFF, APRIL, TWE-PRIL: who's who?
Daridon C; Youinou P; Pers JO
Autoimmun Rev; 2008 Feb; 7(4):267-71. PubMed ID: 18295728
[TBL] [Abstract][Full Text] [Related]
30. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
33. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
34. Two related ligands of the TNF family, BAFF and APRIL, in rabbit: molecular cloning, 3D modeling, and tissue distribution.
Guan ZB; Shui Y; Zhang SQ
Cytokine; 2007 Sep; 39(3):192-200. PubMed ID: 17822916
[TBL] [Abstract][Full Text] [Related]
35. Elevated serum levels of APRIL, but not BAFF, in patients with atopic dermatitis.
Matsushita T; Fujimoto M; Echigo T; Matsushita Y; Shimada Y; Hasegawa M; Takehara K; Sato S
Exp Dermatol; 2008 Mar; 17(3):197-202. PubMed ID: 17979975
[TBL] [Abstract][Full Text] [Related]
36. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
[TBL] [Abstract][Full Text] [Related]
37. Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case-control study.
Eilertsen GØ; Van Ghelue M; Strand H; Nossent JC
Rheumatology (Oxford); 2011 Dec; 50(12):2197-205. PubMed ID: 21984763
[TBL] [Abstract][Full Text] [Related]
38. Serum BAFF and APRIL levels in patients with PBC.
Migita K; Ilyassova B; Kovzel EF; Nersesov A; Abiru S; Maeda Y; Komori A; Ito M; Yano K; Yatsuhashi H; Shimoda S; Ishibashi H; Nakamura M
Clin Immunol; 2010 Feb; 134(2):217-25. PubMed ID: 19840904
[TBL] [Abstract][Full Text] [Related]
39. Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome.
Fühlhuber V; Bick S; Kirsten A; Hahn A; Gerriets T; Tschernatsch M; Kaps M; Preissner KT; Blaes F; Altenkämper S
J Neuroimmunol; 2009 May; 210(1-2):87-91. PubMed ID: 19339060
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis.
Begum-Haque S; Sharma A; Christy M; Lentini T; Ochoa-Reparaz J; Fayed IF; Mielcarz D; Haque A; Kasper LH
J Neuroimmunol; 2010 Feb; 219(1-2):47-53. PubMed ID: 20034680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
